Copart [CPRT] vs Ul Solutions [ULS] Detailed Stock Comparison
Copart
NASDAQ
Loading...
Ul Solutions
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Copart wins in 11 metrics, Ul Solutions wins in 7 metrics, with 0 ties. Copart appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Copart | Ul Solutions | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.52 | 42.83 | Copart |
| Price-to-Book Ratio | 5.07 | 14.76 | Copart |
| Debt-to-Equity Ratio | 1.15 | 85.67 | Copart |
| PEG Ratio | 26.48 | 42.33 | Copart |
| EV/EBITDA | 21.17 | 24.76 | Copart |
| Profit Margin (TTM) | 32.21% | 11.60% | Copart |
| Operating Margin (TTM) | 37.27% | 15.32% | Copart |
| EBITDA Margin (TTM) | 37.27% | 15.32% | Copart |
| Return on Equity | 18.44% | 42.71% | Ul Solutions |
| Return on Assets (TTM) | 12.02% | 10.40% | Copart |
| Free Cash Flow (TTM) | $961.57M | $287.00M | Copart |
| Dividend Yield | N/A | 0.52% | N/A |
| 1-Year Return | -10.54% | 43.64% | Ul Solutions |
| Price-to-Sales Ratio (TTM) | 9.71 | 4.94 | Ul Solutions |
| Enterprise Value | $40.29B | $14.63B | Copart |
| EV/Revenue Ratio | 8.78 | 5.04 | Ul Solutions |
| Gross Profit Margin (TTM) | 45.58% | 48.37% | Ul Solutions |
| Revenue per Share (TTM) | $5 | $15 | Ul Solutions |
| Earnings per Share (Diluted) | $1.51 | $1.67 | Ul Solutions |
| Beta (Stock Volatility) | 1.07 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Copart vs Ul Solutions Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Copart | -0.37% | -1.17% | -5.69% | -24.17% | -20.97% | -17.83% |
| Ul Solutions | 1.08% | 4.05% | 0.43% | 27.94% | 33.21% | 47.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Copart | -10.54% | 43.24% | 86.54% | 923.89% | 1,994.12% | 2,964.90% |
| Ul Solutions | 43.64% | 109.42% | 109.42% | 109.42% | 109.42% | 109.42% |
Performance & Financial Health Analysis: Copart vs Ul Solutions
| Metric | CPRT | ULS |
|---|---|---|
| Market Information | ||
| Market Cap | $44.56B | $14.34B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 8,255,911 | 405,659 |
| 90 Day Avg. Volume | 7,687,357 | 685,423 |
| Last Close | $46.28 | $73.17 |
| 52 Week Range | $45.52 - $64.38 | $44.84 - $73.98 |
| % from 52W High | -28.11% | -1.09% |
| All-Time High | $64.38 (Nov 25, 2024) | $73.98 (Jun 25, 2025) |
| % from All-Time High | -28.11% | -1.09% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.05% |
| Quarterly Earnings Growth | 0.06% | 0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.32% | 0.12% |
| Operating Margin (TTM) | 0.37% | 0.15% |
| Return on Equity (TTM) | 0.18% | 0.43% |
| Debt to Equity (MRQ) | 1.15 | 85.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.08 | $4.85 |
| Cash per Share (MRQ) | $4.53 | $1.33 |
| Operating Cash Flow (TTM) | $1.80B | $537.00M |
| Levered Free Cash Flow (TTM) | $873.61M | $220.75M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.52% |
| Last 12-Month Dividend | N/A | $0.37 |
Valuation & Enterprise Metrics Analysis: Copart vs Ul Solutions
| Metric | CPRT | ULS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.52 | 42.83 |
| Forward P/E | 26.48 | 42.33 |
| PEG Ratio | 26.48 | 42.33 |
| Price to Sales (TTM) | 9.71 | 4.94 |
| Price to Book (MRQ) | 5.07 | 14.76 |
| Market Capitalization | ||
| Market Capitalization | $44.56B | $14.34B |
| Enterprise Value | $40.29B | $14.63B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.78 | 5.04 |
| Enterprise to EBITDA | 21.17 | 24.76 |
| Risk & Other Metrics | ||
| Beta | 1.07 | N/A |
| Book Value per Share (MRQ) | $9.08 | $4.85 |
Financial Statements Comparison: Copart vs Ul Solutions
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CPRT | ULS |
|---|---|---|
| Revenue/Sales | $1.21B | $705.00M |
| Cost of Goods Sold | $659.45M | $364.00M |
| Gross Profit | $552.27M | $341.00M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $451.55M | $109.00M |
| EBITDA | $506.07M | $154.00M |
| Pre-Tax Income | $502.80M | $94.00M |
| Income Tax | $97.47M | $23.00M |
| Net Income (Profit) | $405.34M | $71.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CPRT | ULS |
|---|---|---|
| Cash & Equivalents | $2.37B | $267.00M |
| Total Current Assets | $5.36B | $998.00M |
| Total Current Liabilities | $657.13M | $804.00M |
| Long-Term Debt | $81.27M | $803.00M |
| Total Shareholders Equity | $8.80B | $984.00M |
| Retained Earnings | $7.70B | $291.00M |
| Property, Plant & Equipment | $97.68M | $1.62B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CPRT | ULS |
|---|---|---|
| Operating Cash Flow | $704.64M | $240.00M |
| Capital Expenditures | $-124.08M | N/A |
| Free Cash Flow | $572.92M | $103.00M |
| Debt Repayment | $-4,000 | $-152.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CPRT | ULS |
|---|---|---|
| Shares Short | 28.63M | 2.61M |
| Short Ratio | 3.62 | 3.16 |
| Short % of Float | 0.04% | 0.05% |
| Average Daily Volume (10 Day) | 8,255,911 | 405,659 |
| Average Daily Volume (90 Day) | 7,687,357 | 685,423 |
| Shares Outstanding | 962.97M | 200.17M |
| Float Shares | 886.48M | 61.50M |
| % Held by Insiders | 0.09% | 0.01% |
| % Held by Institutions | 0.87% | 1.17% |
Dividend Analysis & Yield Comparison: Copart vs Ul Solutions
| Metric | CPRT | ULS |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.37 |
| Last 12-Month Dividend Yield | N/A | 0.52% |
| 3-Year Avg Annual Dividend | N/A | $0.16 |
| 3-Year Avg Dividend Yield | N/A | 0.27% |
| 3-Year Total Dividends | N/A | $0.49 |
| Ex-Dividend Date | N/A | Feb 28, 2025 |